Evaluation of tablets divisibility in pharmacoeconomic aspects Tabletlerde bölünebilirliǧin farmakoekonomik açi{dotless}dan deǧerlendirilmesi


Creative Commons License

Yemşen Ö., Canefe K.

Journal of Clinical and Analytical Medicine, cilt.5, sa.6, 2014 (SCI-Expanded, Scopus, TRDizin) identifier

Özet

Aim: Divisibility and dose homogeneity in scored tablets which form a part of the drugs those are in tablet forms in Turkey and have an extensive implementation area in drug therapy have a high importance for patient compliance and safety. In this study, it is aimed to evaluate Turkey's pharmaceutical market about cost differences of dividing scored tablets which has different unit quantities of the same active substance. Material and Method: In Turkey's pharmaceutical market, to detect cost differences of dividing scored tablets which has different unit quantities of the same active substance, All Drug's Price List that has been published on Turkish Medicine and Medical Devices Agency's web site is evaluated by using cost-minimization analysis method. Results: It is determined that the use of scored tablets make a price advantage of about 70%. Discussion: In conclusion, on package leaflets and outer packaging information those are prepared for the use of patients, the warning "Don't divide, crack or swallow the tablets unless otherwise recommended by your doctor." should be stated and it is considered that it would be useful if the patient is informed about divisibility by the pharmacist.